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This critical synopsis of prior work by Clive Beggs is submitted in support of a PhD 
by published work.  The work  focuses on venous and cerebrospinal  fluid  (CSF) 
anomalies associated with multiple sclerosis (MS) and other neurological diseases.
MS is characterized by  focal inflammatory lesions, which  are often venocentric. 
Recently a vascular syndrome, chronic cerebrospinal venous insufficiency (CCSVI) 
has been linked with MS. This  syndrome, which is  characterized by constricted 
cerebral  venous outflow, has become mired in controversy, with various studies 
producing  conflicting  findings,  with  the  result  that  the  science  associated  with 
CCSVI has become obscured.
Clive  Beggs  work  seeks  to  bring  clarity  to  the  debate  surrounding  CCSVI  by 
characterizing physiological changes associated with constricted cerebral venous 
outflow.  The  work  submitted  here  involves  collaborative  studies  with  Robert 
Zivadinov (University of Buffalo), Paolo Zamboni (University of Ferrara), and Chih-
Ping Chung (National Yang Ming University of Medicine). The key findings of these 
studies  are:  (i)  MS  patients,  diagnosed  with  CCSVI,  exhibit  greatly  increased 
hydraulic  resistance  of  the  cerebral  venous  drainage  system;  (ii)  MS  patients 
experience loss of the small cerebral veins; (iii) MS patients exhibit reduced CSF 
bulk  flow,  consistent  with  mild  venous  hypertension;  (iv)  MS  patients  exhibit 
increased CSF pulsatility in the  Aqueduct of Sylvius, which appears to be linked 
with mild venous hypertension associated with CCSVI; and (v) jugular venous reflux 
is associated with white matter and parenchymal volumetric changes in Alzheimer’s 
patients. Collectively, these findings suggest that extracranial venous anomalies are 
associated with changes in the intracranial physiology. 
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Glossary of Abbreviations
AD: Alzheimer’s disease
Aβ: amyloid-β
AV: arachnoid villi
AoS: aqueduct of Sylvius
ACS: aqueductal characteristic signal
CNS: central nervous system
CBF: cerebral blood flow
CBV: cerebral blood volume
CPP: cerebral perfusion pressure
CSF: cerebrospinal fluid
CCSVI: chronic cerebrospinal venous insufficiency
CIS: clinically isolated syndrome
DAWM: dirty appearing white matter
DFV: distance from vein
ECDS: echo colour Doppler sonography
GM: grey matter
HIF: hypoxia-inducible factor
ICP: intracranial pressure
IJV: internal jugular vein
JVR: jugular venous reflux
MRI: magnetic resonance imaging
MRV: magnetic resonance venography
MTT: mean transit time
MCI: mild cognitive impairment
MS: multiple sclerosis
NNF: net negative CSF flow
NPF: net positive CSF flow
NPH: normal pressure hydrocephalus
NBV: normalized brain volume
NLVV: normalized lateral ventricle volume
OND: other neurological disease
ROC: receiver operating characteristics
RTVV: relative total venous volume
SVD: singular value decomposition
SAS: sub-arachnoid space
SSS: superior sagittal sinus
SWI: susceptibility-weighted imaging
TOF: time-of-flight MR venography
TRICKS: time-resolved imaging of contrast kinetics
VRF: venous relative fraction
WM: white matter
WB: whole brain
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Chapter 1: Introduction
1.0 Introduction
This  document  is  a  synopsis  of  the  published  work  of  Clive  Beggs  (hereafter 
referred  to  as  the  author)  relating  to  venous  and  cerebrospinal  fluid  (CSF) 
anomalies associated with multiple sclerosis (MS), which is herewith submitted for 
a PhD by published work.
1.1 Selected publications
The body of published work submitted for this PhD is itemized in Table 1, which 
comprises ten journal papers, copies of which are included in Appendix B. These 
papers have been selected either because Clive Beggs is the principal author, or 
because  he  has  made  a  substantial  contribution  to  the  respective  studies. 
Additional, supporting material, summarized in Table 2, is included in Appendix C. 
This comprises two journal papers relating to venous angioplasty/anomalies and 
MS, in which the author made a lesser contribution.
1.2Justification for the work
Multiple sclerosis is a chronic, autoimmune, inflammatory disease characterized by 
demyelination of the neurons in the central nervous system (CNS) (Lassmann et 
al.,  2007),  which  is  thought  to  affect  as  many  as  2.5  million  people  worldwide 
(WHO, 2008). Although first described in 1868 (Clanet, 2008), its aetiology remains 
unknown. Since the earliest years of research into MS, it has been noted that MS 
plaques are often venocentric. Dawson (Dawson, 1916) observed that finger-like 
plaques  form  at  the  junction  of  the  subependymal  and  medullary  veins  in  the 
periventricular white matter (WM). Putnam and Adler (Putnam and Adler, 1937), 
commenting  on  the  appearance  of  these  ’Dawson’s  fingers’,  observed  that  the 
medullary  veins  were enclosed  in  a  sleeve  of  plaque,  and that  adjacent  to  the 
plaques  the  veins  were  grossly  distorted  and  distended.  Others  (Fog,  1963; 
Kermode et al., 1990; Kidd et al., 1999; Tallantyre et al., 2011; Tan et al., 2000)  
have also shown that inflammatory lesions tend to form axially around veins in the 
WM in MS patients. Kidd et al (Kidd et al., 1999) demonstrated that  grey matter 
(GM) MS lesions were also perivenous in nature – something confirmed by other 
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researchers (Gilmore et al., 2009; Pitt et al., 2010; Tan et al., 2000; Young et al.,  
2010).  Yet the connection with the venous system has largely been ignored, with 
the focus of MS research turning instead towards the involvement of the immune 
system in the disease (Martin et al., 1992; Sospedra and Martin, 2005). 
Table 1. Published journal papers submitted for inclusion in the PhD.
Reference Journal Paper Contribution
(Beggs, 
2010)
Beggs CB. Multiple sclerosis appears to be associated with 
cerebral venous abnormalities. Annals of Neurology 2010, 68: 
560-561
PR*
(Zamboni 
et al., 
2012)
Zamboni  P,  …  Shepherd  SJ,  Beggs  CB. Assessment  of 
cerebral  venous return by a novel plethysmography method. 
Journal of Vascular Surgery 2012. 56: 677-685
PR***
(Beggs et 
al., 2012a)
Beggs CB, Shepherd SJ, Zamboni P. Cerebral venous outflow 
resistance and interpretation of cervical plethysmography data 
with respect to the diagnosis of chronic cerebrospinal venous 
insufficiency. Phlebology. 2012. doi: 
10.1258/phleb.2012.012039:1-9
PR**
(Zivadinov 
et al., 
2011a)
Zivadinov R, … Beggs CB, Dwyer MG, Weinstock-Guttman B. 
Decreased brain venous vasculature visibility on susceptibility-
weighted imaging venography in patients with multiple 
sclerosis is related to chronic cerebrospinal venous 
insufficiency. BMC Neurology 2011. 11: 128
PR***
(Beggs et 
al., 2012b)
Beggs CB, … Zivadinov R. Sensitivity and specificity of SWI 
venography  for  detection  of  cerebral  venous  alterations  in 
multiple sclerosis. Neurological Research 2012. 34: 793-801
PR**
(Magnano 
et al., 
2012)
Magnano C, … Beggs CB, Zivadinov R. Cine cerebrospinal 
fluid imaging in multiple sclerosis. Journal of Magnetic 
Resonance Imaging 2012. 36: 825-834 
PR***
(Beggs et 
al., 2013b)
Beggs CB, … Zivadinov R. Aqueductal cerebrospinal fluid 
pulsatility in healthy individuals is affected by impaired cerebral 
venous outflow.  Journal of Magnetic Resonance Imaging 
2013. doi: 10.1002/jmri.24468
PR**
(Chung et 
al., 2013)
Chung CP, Beggs CB, … Zivadinov R. Jugular venous 
reflux and white matter abnormalities in Alzheimer's 
disease.  Journal of Alzheimer’s Disease. 2013. doi: 
10.3233/JAD-131112
PR***
(Beggs et 
al., 2013a)
Beggs CB, Chung CP,… Zivadinov R. Jugular venous reflux 
and brain parenchyma volumes in elderly patients with mild 
cognitive impairment and Alzheimer’s disease. BMC 
Neurology. 2013. 13: 157 
PR**
(Beggs, 
2013)
Beggs CB. Venous Haemodynamics in Neurological 
Disorders: An Analytical Review with Hydrodynamic Analysis. 
BMC Medicine. 2013. 11: 142
PR*
P = available in the public domain; R = refereed journal paper; * = sole author; 
** = principal author; *** = joint author
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Table 2. Supporting material
Reference Journal Paper Contribution
(Zivadinov 
et al., 
2013)
Zivadinov R, … Beggs C, Salvi F, Zamboni P.  Changes of 
cine  cerebrospinal  fluid  dynamics  in  patients  with  multiple 
sclerosis treated with percutaneous transluminal angioplasty: 
a  case-control  study. Journal  of  Vascular  and 
Interventional Radiology. 2013. 24: 829-838
PR***
(Haacke et 
al., 2012a)
Haacke EM, Beggs CB, Habib C. The role of venous 
abnormalities in neurological disease. Review in Recent 
Clinical Trials 2012. 7: 100-116 
PR***
P = available in the public domain; R = refereed journal paper; *** = joint author
In 2009, Zamboni et al published an ultrasonic study (Zamboni et al., 2009c) linking 
a vascular syndrome, chronic cerebrospinal venous insufficiency (CCSVI), with MS. 
This vascular condition is characterized by stenotic lesions in the extracranial veins, 
resulting in restricted venous outflow from the brain and collateral rerouting of the 
blood flow back to the heart  (Zamboni  et  al.,  2009a),  as illustrated in Figure 1.  
Patients with CCSVI exhibit occlusion of the principal cerebral drainage pathways 
(e.g.  the  internal  jugular  veins  (IJVs)  and  azygos  vein)  which can  take  several 
forms, including intraluminal septa, membranes, and immobile valves, as well as 
segmentary hypoplasia of the veins (Zamboni and Galeotti, 2010). Zamboni et al 
also  found  evidence  that  CCSVI  might  be  associated  with  alterations  in  the 
dynamics of the intracranial CSF system. In a pilot study, they found that CCSVI in 
patients with MS was associated with:  (i)  a reduction of  CSF bulk flow; and (ii)  
increased CSF pulsatility in the Aqueduct of Sylvius (AoS) (Zamboni et al., 2009d). 
Collectively, these findings raise intriguing questions regarding the role of vascular 
anomalies in the pathophysiology of MS. As such, they highlight the need for further 
research into the subject and, in particular, the need for new insights into the role of 
the intracranial fluid system in MS.
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Figure 1.  Example of CCSVI: collateral flow through the thyroid veins in a multiple 
sclerosis patient due to stenosis of the left internal jugular vein (Beggs et al., 
2012a).
1.3Context and scope of the work
The author is a biomedical engineer who has worked in the field of neurovascular 
research since 2009 and who is currently collaborating with three clinical research 
groups: Prof. Robert Zivadinov’s team at the University of Buffalo, USA; Prof. Paolo 
Zamboni’s team at the University of Ferrara, Italy; and Dr Chih-Ping Chung’s team 
at the National Yang Ming University of Medicine, Taipei, Taiwan. His role in these 
collaborations is a translational one, applying a systems engineering approach to 
analyze and interpret physiological data collected by his clinical colleagues, with the 
aim of gaining new insights in the role that venous and CSF anomalies might play  
in MS and other neurological conditions. 
In his various collaborations, the author has conceptually lead and developed the 
fluid  dynamics  strand  of  the  work.  This  has  involved:  (i)  giving  strategic 
presentations to educate and inform the teams in Ferrara and Buffalo regarding the 
dynamics of the intracranial fluid system; (ii) critically appraising the work of others, 
so as to inform the direction of the collaborative research; and (iii) using advanced 
analytical  techniques  to  interpret  and  synthesize  data  collected  by  clinical 
colleagues.  The author’s knowledge of the intracranial fluid system, together with 
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his expertise in data analysis and mathematical modeling has enabled him to make 
key contributions to the body of work submitted here. As such, he has pioneered 
the application of fluid mechanics to MS research; a subject that hitherto has not 
been associated with fluid dynamics. 
Although  the  work presented  here  forms  part  of  a  larger  ongoing  research 
programme that includes other neurological conditions, such as normal pressure 
hydrocephalus (NPH) (Beggs, 2013) and Alzheimer’s disease (AD) (Beggs et al., 
2013a; Chung et al., 2013), the primary focus of this PhD thesis is MS. Having said 
this, where relevant the role of venous anomalies in other neurological disease will 
be discussed in support of the arguments relating to MS. For this reason the author 
has included papers that relate to venous anomalies associated with AD, NPH and 
other neurological conditions.
1.4Aims and objectives
The overall aim of the work has been to characterize venous and CSF anomalies in 
patients  with  MS,  and  thus  gain  new insights  into  the  role  that  fluid  dynamics 
(haemodynamics) might play in the pathophysiology of the disease.
The specific objectives were to:
(i). Use cervical plethysmography to quantify the hydraulic characteristics of the 
cerebral venous drainage system in patients with MS and in healthy controls. 
(ii). Identify and characterize changes in the cerebral venous vasculature of MS 
patients using susceptibility-weighted magnetic resonance imaging (MRI).
(iii). Develop a methodology for quantifiably distinguishing between MS patients 
and healthy controls using cerebral venous data acquired through MRI.
(iv). Characterize and quantify altered CSF dynamics in patients with MS.
(v). Establish whether or not constricted cerebral venous outflow is associated 
with altered CSF dynamics in healthy individuals.
(vi). Establish whether or not constricted cerebral venous outflow can account for 
the changes in cerebral blood flow and CSF bulk flow observed in patients 
with MS.  
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(vii). Establish  whether  or  not  anomalies  in  cerebral  venous  outflow  are  
associated with other neurological conditions.
(viii). Synthesize  the  work,  in  order  to  gain  deeper  insights  into  possible  
patho/neuro-physiological mechanisms associated with constricted cerebral 
venous outflow. 
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Chapter 2: Background to the research
2.0  Introduction
This chapter presents an overview of the background research underpinning the 
work of the author and his collaborators. 
2.1  Background research
Although  MS  is  known  be  a  chronic  inflammatory  disease  characterized  by 
demyelination of  the neurons in the CNS (Lassmann et al.,  2007),  its  aetiology 
remains unknown. In recent decades most of the research undertaken in MS has 
focused on the  involvement of the immune system in the disease (Martin et al., 
1992; Sospedra and Martin, 2005). While this work has yielded useful insights into 
MS, much still remains unknown. In particular, the role of the vascular system in the 
progression  of  MS  is  poorly  understood.  For  many  years  there  has  been  a 
suspicion that veins might be involved in the aetiology of the disease. As early as 
1916, Dawson (Dawson, 1916) observed finger-like plaques at the junction of the 
subependymal and medullary veins in the periventricular WM of MS patients (see 
Figure 2). Later, Putnam and Adler (Putnam and Adler, 1937) observed that the 
medullary  veins  at  this  junction  were  enclosed  in  a  sleeve  of  plaque,  and  that 
upstream of these plaques the veins were grossly distorted and distended (see 
Figure 3). Others (Fog, 1963; Kermode et al., 1990; Kidd et al., 1999; Tan et al.,  
2000) have also shown that inflammatory lesions tend to form axially around veins 
in the WM in MS patients, with Tallantyre et al (Tallantyre et al., 2011) finding 80% 
of  MS  lesions  to  be  perivenous  in  nature.  Kidd  et  al  (Kidd  et  al.,  1999) 
demonstrated that GM lesions were also associated with veins, with the majority of 
cortical  lesions arising within the territory of the principal  vein V5, whose course 
begins in the WM (Duvernoy et al., 1981) and the remaining cortical lesions forming 
in the region drained by its branches or that of the superficial veins. Others have 
confirmed  Kidd et al’s observations, finding the intracortical  (Gilmore et al., 2009; 
Pitt  et  al.,  2010;  Young  et  al.,  2010),  leucocortical  (Gilmore  et  al.,  2009) and 
subcortical (Tan et al., 2000) lesions to be perivenous in nature.
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Figure 2. FLAIR images show bilateral periventricular white matter changes 
(Dawson’s fingers) in a 50-year old female with a long-standing diagnosis of 
multiple sclerosis. (source: http://www.mypacs.net/cases/DAWSON-FINGERS-IN-
MULTIPLE-SCLEROSIS-4011233.html 16th July 2013)
Figure 3.  Illustration from Putnam and Adler (Putnam and Adler, 1937) showing a 
Dawson’s finger with distended medullary vein.
It is thought that the infiltration of leukocytes across the blood-brain barrier (BBB) 
into the CNS is an essential step in the pathophysiology of MS. Chemokines on the 
endothelial  lumen bind to receptors on the leukocytes and initiate a cascade of 
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events that culminate in breaching of the BBB (Holman et al., 2011). The ease with 
which  the  leukocytes  are  able  to  enter  the  brain  parenchyma depends  on  the 
chemokines  present  and  the  characteristics  of  the  endothelia.  Wakefield  et  al 
(Wakefield  et  al.,  1994)  found  morphological  changes in  the venous  endothelia 
which progressed to  occlusive vascular  inflammation.  They proposed that  these 
changes were the precursor to lesion formation and suggested that demyelination 
may have an ischaemic basis in MS. Aboul-Enein and Lassmann (Aboul-Enein and 
Lassmann,  2005)  observed  similarities  between  the  tissue  injury  found  in 
inflammatory brain lesions and that found under hypoxic conditions in the CNS. Ge 
et al (Ge et al.,  2008) identified subtle venous wall  signal changes in small  MS 
lesions, which they interpreted as early-stage vascular changes. These changes 
are thought to be the result  of  early  ischaemic injury, marking the beginning of 
trans-endothelial migration of vascular inflammatory cells, before any apparent BBB 
breakdown. Werring et al (Werring et al., 2000) found that the formation of lesions 
was preceded by subtle progressive alterations in tissue integrity, and Wuerfel et al 
(Wuerfel et al., 2004) found that changes of perfusion parameters, such as cerebral 
blood flow (CBF), cerebral blood volume (CBV) and mean transit time (MTT) were 
detectable prior to the BBB breakdown. They concluded that in MS, inflammation is 
accompanied by altered local perfusion, which can be detected prior to permeability 
of  the  BBB.  Lochhead  et  al  (Lochhead  et  al.,  2010)  using  a  rat  model, 
demonstrated that hypoxia followed by re-oxygenation altered the conformation of 
the  occludin  in  the  tight  junctions  between  the  endothelial  cells,  resulting  in 
increased BBB permeability.  In  doing  so,  they  confirmed  the  findings  of  earlier 
studies undertaken by the same team (Witt  et  al.,  2003; Witt  et  al.,  2008).  The 
earliest detectable event in the development of WM lesions is thought to be an 
increase  in  the  permeability  of  the  BBB  (Kermode  et  al.,  1990)  followed  by 
inflammation and demyelination. Others have implicated tight junction abnormalities 
with  increased BBB permeability  and lesion  formation  in  MS (Kirk  et  al.,  2003; 
Leech et al., 2007; Plumb et al., 2002). 
In 2009,  Zamboni et al published a paper (Zamboni et al., 2009c) linking  CCSVI 
with MS. This condition is  characterized by constricted venous outflow from the 
brain due to occlusions, which impede the principal pathways resulting in collateral 
rerouting of the venous blood (Zamboni et al., 2009a).  CCSVI has proven to be a 
highly  contentious  issue  (Beggs,  2010;  Doepp  et  al.,  2010),  with  a  number  of 
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researchers doubting its validity as a physiological phenomenon (Baracchini et al., 
2012; Doepp et al., 2010; Doepp et al., 2011; Khan et al., 2010; Mayer et al., 2011; 
Wattjes et al., 2011a). Notwithstanding this, from a fluid mechanics standpoint there 
is  reason  to  believe  that  CCSVI-like  restrictions  might  increase  the  hydraulic  
resistance of the extracranial venous pathways and that this in turn might increase 
the venous pressure in the dural  sinuses;  something which hypothetically  could 
alter the dynamics of the intracranial CSF system and potentially influence CBF. 
Given that patients with MS frequently exhibit substantially reduced CBF (Adhya et 
al., 2006; Ge et al., 2005; Law et al., 2004; Varga et al., 2009), it can therefore be  
hypothesized that CCSVI might play a role in the pathophysiology of MS.
The results obtained by researchers regarding CCSVI have been very mixed.  For 
example, Zamboni et al (Zamboni et al., 2009c), Zivadinov et al (Zivadinov et al.,  
2011c), Al-Omari and Rousan (Al-Omari and Rousan, 2010), Simka et al (Simka et 
al., 2010), Zaniewski et al (Zaniewski et al., 2013),  Haacke et al (Haacke et al., 
2012b; Utriainen et al.,  2012)  and  Yamout et al  (Yamout et al.,  2010)  all  found 
CCSVI-like  venous  anomalies  to  be  strongly  associated  with  MS.  By  contrast 
Doepp et al (Doepp et al., 2010), Krogias et al (Krogias et al., 2010), Baracchini et 
al  (Baracchini  et  al.,  2011) and Mayer  et  al  (Mayer  et  al.,  2011), Wattjes  et  al 
(Wattjes  et  al.,  2011b)  and Sundstrom et  al  (Sundstrom et  al.,  2010)  found no 
significant difference between the venous characteristics of healthy controls and 
MS  patients.  Furthermore,  CCSVI-like  abnormalities  are  not  exclusive  to  MS 
patients and have been found in lesser numbers in healthy controls (Centonze et 
al.,  2011; Mancini  et al.,  2012; Zivadinov et  al.,  2011c) and in  those with other 
neurological disease (OND) (Zivadinov et al., 2011c). For example, Zivadinov et al  
(Zivadinov  et  al.,  2011c),  in  a  study  involving  499  individuals  found  CCSVI 
prevalence rates to be 56.1% in MS patients, 42.3% in those with OND, 38.1% in 
individuals with clinically isolated syndrome (CIS), and 22.7% in controls. Centonze 
et al (Centonze et al., 2011) achieved similar results in a study involving  84 MS 
patients and 56 healthy subjects, finding CCSVI in 50% of the MS patients and in 
36% of the healthy controls. In a study involving 103 MS patients and 42 healthy 
controls, Mancini et al (Mancini et al., 2012) found CCSVI to be present in 77% of 
the MS patients studied, verses 28% in controls. Bastianello et al (Bastianello et al.,  
2011), in a large multi-centre study involving  710 MS patients, found that 86% of 
MS patients exhibited characteristics of CCSVI. Collectively, these findings suggest 
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that although CCSVI-like venous anomalies are found in healthy individuals, they 
are more prevalent in individuals with MS. This raises intriguing questions as to 
whether CCSVI represents a pathology, as originally suggested by Zamboni et al  
(Zamboni  et  al.,  2009c),  or  alternatively  an  extreme  variation  in  the  natural 
physiology  of  the  venous  system.  Unlike  the  arterial  system,  which  generally 
exhibits a high degree of consistency between individuals, the venous system can 
display considerable variation in the cerebral drainage pathways – something that 
is thought to be associated with congenital and developmental factors (Lee et al.,  
2010). While the link between CCSVI and MS is unclear, it may be that CCSVI 
represents a natural variation of the venous system, which predisposes individuals, 
through some unknown mechanism, to develop MS. 
As well as having an effect on the extracranial venous system, there is evidence 
that CCSVI might be associated with changes in the dynamics of the intracranial 
CSF system. In a pilot study, Zamboni  et al (Zamboni et  al.,  2009d) found that 
CCSVI in patients with MS was associated with both a large reduction of CSF bulk 
flow, and also increased CSF pulsatility in the AoS. Similarly, Gorucu et al (Gorucu 
et al., 2011) found aqueductal CSF pulsatility to be significantly increased in MS 
patients  compared  with  healthy  controls.  They  also  observed  a  large  average 
reduction in bulk CSF flow in MS patients compared with controls, although unlike 
Zamboni  et al, this result was not significant. Because CCSVI-like restrictions are 
likely to increase the hydraulic resistance of the venous drainage pathways, there is 
reason to believe that CCSVI might induce retrograde venous hypertension in the 
superior sagittal sinus (SSS) of patients with MS. Given that CSF absorption from 
the  sub-arachnoid  space  (SAS)  to  the  SSS  has  been  shown  to  be  directly 
proportional to the pressure difference between these two vessels (Cutler et al., 
1968), one would expect venous hypertension in the dural sinuses to inhibit CSF 
bulk flow in MS patients, just as Zamboni et al and Gorucu et al found. Having said 
this,  Zamboni  et  al’s  and  Gorucu  et  al’s  findings  have  been  challenged  by 
Sundstrom  et al (Sundstrom et al., 2010), who found no significant difference in 
aqueductal CSF pulse between MS patients and healthy controls.  
Despite conflicting evidence, from the above discussion there appears to be a link 
between CCSVI and MS. This opinion is shared by the Canadian Institute of Health 
Research expert panel, which after meta-analysis of the evidence concluded: “Our 
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findings showed a positive association between CCSVI and MS. However,  poor  
reporting of the success of blinding and marked heterogeneity among the studies  
included in our review precluded definitive conclusions” (Laupacis et al., 2011). One 
of the reasons for this  heterogeneity has been the wide variety of methodologies 
used to diagnose CCSVI. For example, Ghezzi et al (Ghezzi et al., 2011) attributed 
the large variability in reported results to differences in the methodologies used to 
diagnose  venous  abnormalities.  This  point  is  highlighted  by  Zivadinov  et  al 
(Zivadinov et al., 2011b), who found conventional magnetic resonance venography 
(MRV)  to  be  of  only  limited  value  when assessing  IJV anomalies.  Echo colour 
Doppler  sonography  (ECDS),  frequently  used  to  diagnose  CCSVI,  may  also 
contribute  to  discrepancies.  The  floppiness  of  the  vessels  involved  and  the 
variability of the venous vasculature can lead to erroneous results, if ECDS is not 
undertaken correctly  (Menegatti  et  al.,  2010;  Parvey et  al.,  1989; Taffoni  et  al.,  
2005). 
In addition to the work relating to MS, there is growing evidence that anomalies of  
the extracranial venous drainage system may be associated with other neurological 
conditions. In a series of related studies Chung and co-workers (Chung and Hu, 
2010; Chung et al., 2010b; Chung et al., 2011) investigated jugular venous reflux 
(JVR) in elderly individuals. Although they specifically did not investigate CCSVI, 
JVR relates to retrograde flow in the IJVs, which was one of the criteria used by 
Zamboni et al to define CCSVI (Zamboni et al., 2009c). Chung et al found JVR to 
be associated with severe age-related WM changes, similar to those associated 
with  leukoaraiosis (Chung et al., 2011). In particular, they found IJV lumen cross-
sectional  area  to  increase  with  age  (Chung  et  al.,  2010b);  something  that 
suggested dilation of the veins due to elevated venous pressure and reduced flow 
velocity.  Chung  et  al (Chung  et  al.,  2010b) postulated  that  if  the  venous 
hypertension exceeds the ability  of the dilation to compensate for the additional  
pressure, then it would compromise the competence of the jugular venous valves, 
with the result that the direction of venous flow could be reversed (especially when 
undergoing  the  Valsalva  maneuver).  They  further  hypothesized  that  this  might 
cause cerebral  venous hypertension,  resulting in reduced CBF (Chung and Hu, 
2010). In a separate study, the same team observed  that patients with migraine 
tend to have less compliant IJVs; something which they postulated, makes these 
individuals susceptible to cerebral venous hypertension (Chung et al., 2010a).
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Chapter 3: The author’s research
3.0  Introduction
This chapter presents an overview of the author’s original work and his contribution 
to the knowledge base. The relevance of the author’s work is also discussed in the 
context of the findings of other researchers.
3.1Narrative framework
In  order  to  contextualize  the  author’s  work  and  to  synthesize  his  findings,  the 
narrative framework shown in Table 4 has been constructed, which describes in a 
cohesive  manner  the  body  of  the  work  presented.  For  ease  of  reference,  this 
narrative groups the author’s various papers into distinct sections, with each section 
dealing  with  a  separate  ‘contribution’,  which  is  mapped  against  the  specific 
objectives identified in section 1.4. To aid the reader, at the start of each narrative 
section a short  paragraph is included summarizing and contextualizing the work 
undertaken.
3.2 Preliminary work
This section discusses preliminary work undertaken by the author, relating  
to the hydraulic resistance of the extracranial venous pathways from the  
brain to the heart. 
While considerable work has been done investigating impaired extracranial venous 
outflow in patients with MS, most studies have simply identified and characterized 
morphological structures, without any consideration of the underlying fluid dynamics 
associated with the venous system. Consequently, research in this field has been 
characterized by a lack of any meaningful hydrodynamic (including haemodynamic) 
analysis.  This  problem  was  first  highlighted  by  the  author  (Beggs,  2010)  who 
performed independent hydrodynamic analysis of venous blood flow data published 
by Doepp  et al (Doepp et al., 2010). Using ECDS, Doepp  et al. acquired venous 
blood  flow  and  vessel  cross-sectional  area  data  from MS patients  and  healthy 
controls.  They undertook statistical  analysis of  this  data and concluded that  the 
cerebral venous characteristics of MS patients were essentially no different from 
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those of healthy controls.  However, Doepp  et al made no attempt to analyse the 
fluid dynamics associated with the system. 
Table 4. Narrative framework for published work.
Section Description Key 
objectives 
met
Beggs et al. - 
relevant 
papers
3.2 Preliminary work This  section  presents  an  overview  of 
preliminary work undertaken by the author 
relating  to  the  hydraulic  resistance  of  the 
extracranial  venous  pathways  from  the 
brain to the heart. 
n.a. (Beggs, 2010)
3.3 Cervical
plethysmography 
This  section  presents  an  overview  of  the 
collaboration between the author and Prof. 
Zamboni,  which  involved the development 
and  application  of  a  novel  cervical 
plethysmography technique to characterize 
and quantify venous hydraulic resistance.
(i) (Beggs et al., 
2012a; 
Zamboni et 
al., 2012)
3.4 Loss of cerebral
veins
This  section  presents  an  overview  of  the 
collaboration between the author and Prof. 
Zivadinov,  which  involved  quantifying  and 
characterizing  loss  of  cerebral  venous 
vasculature in patients with MS.
(ii) & (iii) (Beggs et al., 
2012b; 
Zivadinov et 
al., 2011a)
3.5 CSF dynamics This  section  presents  an  overview  of  the 
collaboration between the author and Prof. 
Zivadinov,  which  involved  quantifying  and 
characterizing  CSF  dynamics  in  patients 
with  MS.  The  impact  of  CCSVI  on  CSF 
pulsatility  in  healthy  individuals  is  also 
considered.
(iv) & (v) (Beggs et al., 
2013b; 
Magnano et 
al., 2012)
3.6 Hydrodynamic
analysis
This  section  presents  hydrodynamic 
analysis  undertaken  by  the  author  which 
seeks to explain various vascular and CSF 
phenomena associated with MS.
(vi) (Beggs, 2013)
3.7 Other
neurological 
conditions
This  section  presents  an  overview  of  the 
collaboration between the author, Dr Chung 
and Prof. Zivadinov relating to the impact of 
JVR  on  the  neuropsychology  of  patients 
with AD. 
(vii) (Beggs et al., 
2013a; Chung 
et al., 2013)
3.8 Discussion of the 
work
In  this  section  the  various  findings  are 
brought  together  and synthesized  to  yield 
new insights regarding the role of venous 
and CSF anomalies in the pathophysiology 
of MS.
(viii) (Beggs, 2013)
Realizing  this  omission,  the  author  independently  analyzed Doepp  et  al’s  data, 
using  a  simple  fluid  mechanics  model.  His  findings  challenged  Doepp  et  al’s 
interpretation of the data, suggesting instead that: (i) the hydraulic resistance of the 
extracranial venous system was greater in the MS patients compared the healthy 
controls when in the upright position; and (ii) the patients with MS exhibited venous 
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hypertension in the dural sinuses when compared with the controls. As such, the 
author’s analysis not only challenged Doepp et al’s findings, but also highlighted a 
major shortcoming in the approach taken by many clinical researchers investigating 
CCSVI. In doing so, he highlighted the need for a systems engineering approach 
when investigating CCSVI.
3.3 Cervical plethysmography
This  section  discusses  the  collaboration  between the  author  and  Prof.  
Zamboni  relating  to  the  development  of  a  novel  passive  cervical  
plethysmography technique for characterizing and quantifying extracranial  
venous blood flow. This work is of importance because it took a radically  
different approach to all the previous studies in the field and demonstrated  
(for the first time) that CCSVI is a real physiological phenomenon, which  
greatly increases the hydraulic resistance to the flow of blood from the  
brain to the heart in patients with MS.  
One explanation for the discrepancies between the various studies investigating 
CCSVI is associated with the ECDS frequently used to diagnose the condition. Due 
to  the  floppiness  of  the  vessels  involved  and  the  variability  of  the  vasculature,  
venous ECDS is open to misinterpretation (Menegatti  et al., 2010) and therefore 
needs to be handled with great care. If venous sonography is not undertaken in an 
appropriate manner, erroneous results can easily be obtained (Parvey et al., 1989; 
Taffoni et al., 2005). Furthermore,  although conventional imaging techniques may 
be  good at  identifying  individual  morphological  anomalies  (e.g.  stenotic  lesions, 
membranes,  etc.),  they  cannot  characterize,  or  quantify,  the  hydrodynamic 
behaviour of the cerebral venous drainage system as a whole. In particular, these 
techniques  cannot  quantify  the  increase  in  hydraulic  resistance  associated  with 
stenotic  veins  and  collateral  rerouting  of  venous  blood  back  to  the  heart.  
Consequently, researchers have found it difficult to obtain quantifiable metrics, with 
which  to  objectively  compare  venous  blood  flow  in  MS  patients  and  healthy 
individuals.
Aware  of  the  inherent  limitations  associated  with  imaging  techniques,  Prof. 
Zamboni developed a passive strain-gauge cervical plethysmography technique for 
15
characterising  cerebral  venous  drainage  (Zamboni  et  al.,  2012).  The 
plethysmography process involved placing a passive cervical collar (i.e. a collar that 
did  not  restrict  the underlying vessels)  around the neck of  subjects.  This  collar 
comprised  a  thin  silicone  rubber  tube  containing  electrically  conductive  indium-
gallium liquid metal that acted as the sensor, and which was connected to a data 
logger. As the collar stretched, it  both elongated and reduced in cross-sectional 
area, thus increasing the electrical resistance of the circuit. By monitoring changes 
in electrical resistance, it was possible to indirectly measure the change in blood 
volume in the cervical veins. Having fitted the collar, the subjects were placed in a 
tilt chair and tilted from the upright to the supine position (see Figure 4); a process 
that caused the venous blood to accumulate in the cervical veins. Once the blood 
volume stabilized, the chair was then tilted forward again into the upright position, 
allowing the accumulated blood to rapidly drain from the neck. By  recording the 
change in volume of the cervical veins it was possible to determine: (i) the rate at 
which blood accumulated in the cervical veins when the subjects were tilted into the 
supine position; and (ii) the rate at which it drained back to the heart when they 
were returned to the upright position. As such, the methodology overcame many of 
the inherent problems associated with the various imaging techniques and enabled 
the dynamics of the whole cerebral venous drainage system to be characterised for 
the first time.   
Figure 4. The operator places the strain gauge collar around the neck of the subject 
and rapidly tilts the chair backward from 90° to 0°. When the blood volume curve 
reaches a plateau, the subject is again tilted forward to the upright position 
(Zamboni et al., 2012).
In a blinded study involving 40 healthy controls (38 CCSVI negative and 2 CCSVI 
positive) and 44 individuals diagnosed with MS (42 CCSVI positive and 2 CCSVI 
negative),  Prof.  Zamboni,  the  author  and  their  co-workers  showed  that  the 
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characteristics  of  the  cerebral venous return in CCSVI positive  individuals  were 
markedly  different  from those  of  the  CCSVI  negative  subjects  (Zamboni  et  al., 
2012).  They  demonstrated  both  that  CCSVI  is  associated  with  MS,  and  that  it 
involves profound changes in the dynamics of  the extracranial  venous drainage 
system. For example, in the CCSVI positive MS patients the mean time required for 
the  bolus  of  accumulated  blood  to  drain  back  to  the  heart  during  the 
plethysmography test was 45% longer than that in the CCSVI negative individuals 
(p<0.001). Furthermore, through principal component analysis, they were able to 
show that CCSVI is associated with much greater heterogeneity of the extracranial 
venous system than that observed in CCSVI negative individuals. The study was 
lead by professor  Zamboni  and the author  who worked closely  together.   Prof. 
Zamboni was responsible for selecting the patients and collecting the data, while 
the  author  was responsible  for  the analysis  and  interpretation of  the  data.  The 
author and Prof. Zamboni drafted the final manuscript with support from the other 
co-authors.      
While  the  above  study  revealed  CCSVI  to  be  a  physiological  phenomenon 
associated  with  MS,  it  did  not  attempt  to  quantify  the  dynamics  of  the  venous 
drainage system. The author therefore developed a mathematical model to quantify 
the  hydraulic  resistance  of  the  cerebral  venous  drainage  system  during  the 
plethysmography test (Beggs et al., 2012a), which he applied to the data collected 
in the previous study. This revealed that the hydraulic resistance of the extracranial 
venous system was on average  63.5% greater  in  those diagnosed with  CCSVI 
compared with the CCSVI negative individuals (p<0.001) (Beggs et al., 2012a). As 
such, the work appears to corroborate the author’s earlier analysis (Beggs, 2010) 
and that of Monti  et al (Monti et al., 2011), who found reduced cerebral venous 
outflow  in  the  upright  position  to  be  strongly  associated  (p<0.0001)  with  MS. 
Furthermore, the author was able to show that CCSVI not only impedes cerebral 
outflow when subjects are in the upright position, it also restricts venous flow back 
to the heart when in the supine position, so that the cervical veins fill at a faster rate 
(p<0.001). 
The plethysmography work described above represents a significant step forward in 
the understanding of CCSVI. Rather than simply identifying morphological features, 
it revealed, for the first time, that CCSVI is associated with profound changes in the 
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overall dynamics of the extracranial venous drainage system. Not only did the work 
demonstrate that cervical plethysmography can be used to characterise cerebral 
venous outflow, it also showed that MS is associated with restricted venous flow 
from the brain to the heart.  In doing so, it helped to clarify the scientific debate 
regarding CCSVI.
3.4  Loss of cerebral veins
This  section  discusses  the  collaboration  between  the  author  and  Prof.  
Zivadinov regarding changes in the cerebral venous vasculature in patients  
with MS. This work is of importance because it was the first of it kind to  
demonstrate that MS is associated with actual loss of the small  cerebral  
veins. Indeed, such was the marked nature of the changes observed, that  
the  author  was  able  to  develop  a  new  diagnostic  metric  for  identifying  
individuals with MS using cerebral venous data alone. These findings are all  
the more intriguing because the changes in the cerebral venous vasculature  
appear to be strongly associated with CCSVI.    
 
In 2009  Ge et al (Ge et al., 2009) published the results of a study in which they 
used susceptibility-weighted imaging  (SWI) MRI to assess reduced visibility of the 
cerebral venous vasculature in patients with MS. They demonstrated significantly 
reduced visibility of periventricular white matter venous vasculature in MS patients 
compared with healthy controls, and attributed this to  hypometabolic status in the 
brain parenchyma of MS patients. Importantly, they interpreted their finding not as 
evidence of any actual loss in the venous vasculature, but rather due to decreased 
levels of venous deoxyhemoglobin resulting in loss of visibility of the veins on the 
MRI scans. This they attributed to decreased levels of oxygen extraction arising 
from reduced metabolic activity in the brain parenchyma of MS patients. 
Ge et al’s study raised intriguing questions as to whether or not the cerebral veins 
were actually disappearing in MS patients. In an attempt to answer this question,  
Prof. Zivadinov, the author and their co-workers performed a pre- and post-contrast 
SWI venography experiment in a study involving 59 MS patients and 33 healthy 
controls (Zivadinov et al., 2011a). By using a combination of contrast enhancement 
and novel  in-house algorithms developed to extract  the venous data, they were 
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able to show that the MS patients were characterised by  significantly decreased 
venous vasculature in the brain parenchyma (see Figure 5), which they attributed to 
morphological changes rather than purely reduced metabolism. In particular, they 
found that patients with MS exhibited a decrease in overall venous volume in veins 
with a diameter <0.3 mm (p<0.0001), with the average distance from vein (DFV) 
score  (defined  as  the  average  distance  of  each  voxel  from  the  closest  voxel 
classified  as  belonging  to  a  vein)  being  significantly  increased  (p<0.0001). 
Interestingly, they also found CCSVI to be present in 79.7% of MS patients and 
18.2% of healthy controls (p<0.0001). Furthermore, subjects diagnosed with CCSVI 
exhibited significantly increased DFV (p<0.0001), and a decreased overall venous 
volume (p<0.003) compared to subjects without CCSVI. 
Figure 5.  Apparent total venous volume (ATVV) in representative examples of a 
healthy control (HC), a relapse-remitting (RR) MS patient, and a secondary 
progressive (SP) MS patient. Note that loss of transcranial medullary and 
periventricular veins in the MS patients (Zivadinov et al., 2011a).
Although Zivadinov et al (Zivadinov et al., 2011a) found MS to be associated with 
loss of visibility in cerebral veins of all sizes; the author identified that the greatest  
reduction was observed in the smallest veins. This implied that the larger collecting 
veins were not disappearing at the same rate as the smaller up-stream ‘tributary’  
veins.  The  author  interpreted  this  as  a  sign  that  the  venous  blood  was  being 
rerouted in patients with MS, with the blood being channeled away from the regions 
of the brain once drained by the missing veins, resulting in under-perfused regions 
of the parenchyma prone to hypoxic stress. As such, this appears to support the 
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findings of a number of researchers (Aboul-Enein and Lassmann, 2005; Lassmann, 
2003; Simon, 2005; Wakefield et al.,  1994) who have implicated hypoxia in the 
formation  of  MS  lesions.  Given  that  ischaemic  damage  is  thought  to  promote 
thickening of the vessel walls and narrowing/occlusion of the lumen in the veins of 
patients  with  leukoaraiosis (Moody et  al.,  1995),  it  may be that  in  MS,  hypoxia 
arising from stasis in the smaller veins induces morphological changes, resulting in 
occlusion and atrophy of these veins.
 
In a separate follow-on study conceived and lead by the author, Beggs et al (Beggs 
et  al.,  2012b) sought  to identify  vascular  visibility  metrics that could be used to 
diagnose MS. To this end Beggs et al identified the  0.3–0.6 mm venous relative 
fraction (VRF) (i.e. relative total venous volume (RTVV) for all vein sizes divided by 
RTVV  for  veins  with  a  diameter  0.3–0.6  mm)  and  the  DFV  as  key  diagnostic 
metrics.  By  determining  the  receiver  operating  characteristics  (ROC)  of  these 
metrics they were able to evaluate their appropriateness as a discriminator between 
MS patients and controls. They also used this methodology to compare 0.3–0.6 mm 
VRF and  DFV with  normalized  brain  volume (NBV),  which  is  one  of  the  most 
popular  ‘non-lesion’  based  metrics  currently  used  to  diagnose  MS.  Using  a 
separate  validation  dataset  Beggs  et  al were  able  to  achieve  sensitivity  and 
specificity  scores  of:  92.9% and 75.0% for  0.3–0.6  mm VRF;  and  100.0% and 
100.0% for  DFV,  which  were  superior  than  the  equivalent  score  of  78.6% and 
75.0%  achieved  for  NBV.  Interestingly,  while  the  new  vascular  metrics  could 
distinguish with great accuracy between the MS patients and the healthy controls, 
they could not distinguish between the relapse-remitting and secondary progressive 
MS patients. This suggests that the cerebral vascular changes observed might be 
an early stage phenomenon in the pathology of MS.
The  two  studies  above  suggest  that  MS  is  associated  with  profound  cerebral 
vascular  changes and that  these changes can be utilized to  help  diagnose the 
condition. Indeed, since Zivadinov et al (Zivadinov et al., 2011a) first published their 
findings, two other teams (Sinnecker et al., 2013; Zeng et al., 2013) have published 
results  that  appear  to  corroborate  their  work.  Sinnecker  et  al  (Sinnecker  et  al., 
2013) in a study involving 38 MS patients and 22 matched healthy controls found 
significantly  decreased  venous  density  in  the  MS  patients  compared  with  the 
healthy  controls.  Interestingly,  they  also  found  that  venous  density  correlated 
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inversely with the periventricular and whole-brain T2 lesion count, suggesting that 
under-perfusion of the brain parenchyma might be involved in T2 lesion formation. 
Zeng et al (Zeng et al., 2013) in a study involving 53 MS patients and 53 healthy  
controls observed decreased mean scores in the internal cerebral veins and their 
main tributaries (i.e. the periventricular veins) in the MS patients compared with the 
controls.  Furthermore,  the  deep  medullary  veins  flowing  into  the  periventricular 
veins  diminished  and  shortened  in  48  patients  with  longer  disease  duration. 
Collectively, the two studies by Zivadinov, the author and their coworkers (Beggs et 
al.,  2012b;  Zivadinov  et  al.,  2011a)  represent  a  significant  step  forward  in 
understanding  the  vascular  changes associated with  MS,  because  they  provide 
independently corroborated evidence that the disease is accompanied by profound 
changes in the intracranial venous vasculature. 
3.5 Cerebrospinal fluid dynamics
This  section  discusses  the  collaboration  between  the  author  and  Prof.  
Zivadinov relating to the changes in the dynamics of the intracranial CSF  
system in patients with MS. This work is important because it demonstrates  
that: (i) reduced CSF bulk flow is a feature of MS; (ii) MS is associated with  
increased CSF pulsatility in the Aqueduct of Sylvius (AoS); and (iii) altered 
CSF pulsatile flow is associated with increased T1- and T2-lesion volumes  
in MS patients.  In addition, the results  of a separate follow-on study are  
presented, in which the impact of CCSVI on CSF dynamics is assessed in  
healthy individuals. Importantly, these reveal that CCSVI is associated with  
similar CSF dynamic alterations in health individuals as those observed in  
MS patients, suggesting that increased CSF pulsatility in MS patients may  
be  caused by  venous  hypertension  in  the  dural  sinuses,  rather  than  by  
neuronal decay. 
Being encased in a rigid enclosure, the brain employs a complex intracranial fluid 
regulatory mechanism to compensate for increased blood flow during systole (see 
Figure 6). This poorly understood system compensates for the transient increase in 
arterial blood entering the cranium during systole, by displacing an approximately 
equal volume of CSF through the foreman magnum into the spinal column (Egnor 
et al., 2002). It does this by employing a sophisticated windkessel mechanism to 
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smooth blood flow through the cerebral capillary bed (Bateman, 2002; Bateman et 
al.,  2008);  something  that  appears  to  be  sensitive  to  changes  in  the  cerebral  
venous system (Bateman, 2007; Bateman, 2008a).
Legend: SSS = superior sagittal sinus; STS = straight sinus; SAS = sub-arachnoid space; CSF =  
cerebrospinal  fluid;  AV =  arachnoid  villi;  CP =  choroid  plexus;  FM =  foramen magnum; WM =  
windkessel mechanism; SR = Staling resistor; VL = lateral ventricle; V3 = third ventricle; V4 = fourth  
ventricle; AoS = aqueduct of Sylvius; IJVs = internal jugular veins; VVs = vertebral veins.
Figure 6. Model of the intracranial space, showing the interactions between the 
arterial and venous blood flows and the CSF (Beggs, 2013).
The intracranial CSF system is characterized by two dynamics. The first of these 
relates  to  its  pulsatile  motion  and  is  driven  by  the  windkessel  mechanism 
associated with the pial  arteries passing through the subarachnoid space (SAS) 
(see Figure 6), while the second relates to the slow bulk flow of CSF (normally in  
the range 0.00496 – 0.00694 mL/heart beat) from the choroid plexus to the superior 
sagittal sinus (SSS) via the arachnoid villi (AV), and other absorption sites within 
the brain parenchyma (Nedergaard, 2013; Weller et al., 2009). While the former is a 
complementary part of the intracranial regulatory system, which balances transient 
changes in fluid volume in and out of the cranium, the latter essentially flushes the 
ventricles  with  a  slow moving stream of  CSF driven by the pressure difference 
between the choroid plexus and the SSS. Given that the choroid plexus is located 
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in the lateral ventricles, it is possible to ‘capture’ both dynamics by simply recording 
CSF flow in the AoS, which connects the third and fourth ventricles. Under normal 
circumstances in healthy individuals the net positive CSF flow (NPF) per heart beat 
(i.e. the CSF flow towards the lateral ventricles) is slightly less than the net negative 
CSF  flow  (NNF)  (i.e.  the  CSF  flow  towards  the  spine),  with  the  mathematical  
difference between the NNF and NPF representing the bulk CSF flow percolating 
through the ventricles.
In 2009 professors Zamboni and Zivadinov published the findings of a pilot study 
(Zamboni et al., 2009d) in which they observed: (i) a 97% reduction in bulk CSF 
flow in MS patients compared with controls; and (ii)  a tendency (not significant) 
towards increased NPF in patients with MS. Noticeably, all  the MS patients (16 
individuals) selected to take part in the study were also CCSVI positive, while all the 
health  controls  (8  individuals)  were  CCSVI  negative.  Given  that  restriction  of 
cerebral venous outflow has been shown to increase the hydraulic resistance of the 
extracranial venous pathways (Beggs et al., 2012a), there is reason to associate 
CCSVI with retrograde venous hypertension in the dural sinuses (Beggs, 2013). If 
this is the case, then CCSVI is likely to decrease the pressure difference between 
the choroid plexus and the SSS, inhibiting absorption of CSF into the SSS (Cutler 
et al.,  1968), thus reducing its bulk flow, just as Zamboni  et al (Zamboni et  al., 
2009d)  observed.
One weakness of Zamboni  et al’s pilot study (Zamboni et al., 2009d) was that all 
the  MS patients  in  the study were CCSVI positive,  making it  difficult  to  identify 
whether the changes observed in the CSF dynamics were attributable to MS or 
CCSVI. In an attempt to clarify this issue, Magnano  et al (Magnano et al., 2012) 
(Prof. Zivadinov and the author were co-authors) undertook a MRI study, involving 
67 MS patients and 35 healthy controls, to investigate CSF pulsatility in the AoS. 
Importantly,  no  attempt  was  made  in  this  study  to  identify  CCSVI-positive  and 
negative  individuals,  so  that  the  results  were  representative  of  the  general  MS 
patient population as a whole, rather than of a particular subset. The results of the 
study proved to be conclusive, revealing a 48% mean decrease in bulk CSF flow in 
the patients with MS (p=0.005) and a 45% increase in mean NPF (p=0.004). Mean 
NNF  was  also  increased  (+24%)  in  the  MS  patients,  although  this  was  not 
significant. As such, the results of Magnano  et al’s study (Magnano et al., 2012) 
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appear to confirm those of Zamboni et al’s pilot study (Zamboni et al., 2009d), and 
suggest that venous hypertension in the dural sinuses is a feature of MS. Magnano 
et al’s results were independently confirmed by Gorucu et al (Gorucu et al., 2011), 
who found aqueductal CSF pulsatility to be significantly increased in MS patients 
compared with healthy controls, with a 37% increase in mean NPF (p=0.010) and a 
30% increase in mean NNF (p=0.015). They also observed a 92% mean reduction 
in bulk CSF flow in MS patients compared with controls, although this result was 
not statistically significant.  
In addition to the findings above, Magnano et al (Magnano et al., 2012) found that 
in the MS patients, there was a significant correlation between pulsatile CSF flow 
and increased T2 lesion volume (NNF r = -0.28; NPF r = 0.30; p = 0.02 for both). A 
moderately strong positive correlation was also observed in relapse-remitting MS 
patients between NPF and normalized lateral ventricle volume (NLVV) (r = 0.60; p < 
0.001).  As  such,  these  results  suggest  that  changes  in  the  dynamics  of  the 
intracranial fluid system may be implicated in the pathophysiology of MS.
The results of  the studies performed by  Zamboni  et al (Zamboni et  al.,  2009d), 
Gorucu et al (Gorucu et al., 2011) and Magnano et al (Magnano et al., 2012) reveal 
a consistent picture; namely that the dynamics of the intracranial CSF system are 
markedly  altered  in  MS  patients  compared  with  healthy  controls,  with  a  trend 
towards reduced CSF bulk flow and an increase in CSF pulsatility in the AoS. NPF 
in  particular,  appears  to  be  increased  in  patients  with  MS.  Strong  evidence 
suggesting that this phenomenon is biomechanical in nature, and associated with 
constricted cerebral venous outflow, comes from an interventional study (the first of 
its kind) by Zivadinov et al (Zivadinov et al., 2013), in which the author was a co-
investigator. This clinical study revealed that the intervention of venous angioplasty 
in MS patients diagnosed with CCSVI, had the effect of reducing CSF pulsatility  
and normalizing the aqueductal pulse. As such, it established a direct link between 
increased aqueductal pulsatility and constricted cerebral venous outflow.
 
While Magnano et al’s study did not investigate CCSVI its findings  are consistent 
with the model that constricted cerebral venous drainage in MS patients induces 
hypertension  in  the  dural  sinuses,  something  that  is  known  to  inhibit  CSF 
absorption from the SAS into the SSS (Cutler et al., 1968). If this is the case, then it 
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can be hypothesized that similar changes in CSF dynamics to those observed in 
MS patients might also be found in healthy individuals who are CCSVI positive. To 
this end, the author designed a follow-on study, which investigated the impact of 
CCSVI  on  CSF  pulsatility  in  healthy  individuals.  This  study  utilized  the  same 
methodology as that used by Magnano et al (Magnano et al., 2012) and involved a 
study  cohort  to  51  healthy  individuals  not  related  to  MS  patients  (32  CCSVI-
negative and 19 age-matched CCSVI-positive subjects). The results of this study 
revealed a statistically  significant 32% increase in CSF NPF towards the lateral 
ventricles  (p=0.008)  in  the  CCSVI  positive  group,  compared  with  the  CCSVI 
negative group. A similar increase was observed in NNF towards the spine in the 
CCSVI positive individuals, but this did not reach significance. A decrease in CSF 
bulk flow was also observed in the CCSVI positive individuals, but again this did not  
reach significance. As such, these findings mirror those of Zamboni et al (Zamboni 
et al., 2009d), Gorucu et al (Gorucu et al., 2011) and Magnano et al (Magnano et 
al.,  2012)  and  suggest  that  CCSVI  is  associated  with  altered  CSF  dynamics, 
irrespective of whether on not MS is present. Collectively, they reinforce the opinion 
that increased aqueductal CSF pulsatility is primarily a biomechanical phenomenon 
associated with restricted venous outflow from the cranium.
While CCSVI appears to be associated mainly with biomechanical changes in the 
intracranial space, this does not preclude the possibility that structural changes may 
also be occurring. Further analysis of the data from the healthy individuals study 
(Beggs et al., 2013b) revealed a 28% increase in the mean cross-sectional area of 
the AoS (i.e. the aqueductal characteristic signal (ACS)) (p=0.021) in the CCSVI 
positive group compared with the CCSVI negative group (see Figure 7), suggesting 
the  presence  of  possible  structural  changes  in  the  brain  parenchyma.  Further 
evidence  of  possible  structural  changes  associated  with  CCSVI  in  healthy 
individuals came from correlation analysis of  the MRI data,  which revealed that 
associations  between  NLVV  and  the  CSF  related  variables  in  CCSVI  positive 
subjects were generally weaker than in the CCSVI negative subjects. For example, 
the  negative  relationship  between  NNF  and  NLVV  was  relatively  strong  in  the 
CCSVI  negative  group  (r=-0.686,  p<0.001),  but  was  lost  in  the  CCSVI-positive 
group  (r=-0.103,  p=0.674)  –  a  change  that  was  significant  using  a  Fisher 
transformation  (p=0.018).  This  finding  was  confirmed  using  a  bespoke  singular 
value  decomposition  (SVD)  analysis  tool,  developed  by  the  author  and  Prof. 
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Shepherd (University of Bradford). When the SVD analysis was performed using 
the  variables  NNF,  NPF and NLVV,  it  was possible  to  distinguish between the 
CCSVI positive and negative individuals with relative accuracy (sensitivity = 73.7%; 
specificity = 71.9%; p=0.025), as can be seen in Figure 8. These findings suggest 
that CCSVI is associated with systemic changes in the intracranial physiology of 
healthy individuals, which alter the relationship between CSF pulsatility and lateral  
ventricle size.
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Figure 7. Sequential ensemble mean ACS over a cardiac cycle for both the CCSVI 
positive and negative groups. Between groups mean ACS, p=0.021. The phases of 
cycle where the difference between the signals is significant (p<0.050) are 8-10, 14-
15, 18-28 and 30-32. (Error bars represent one standard deviation.)
Collectively, the results of the studies performed by the author and his co-workers 
indicate  the altered CFS dynamics observed in  MS patients  is  probably  due to 
biomechanical changes associated with constricted cerebral venous outflow rather 
than  neuronal  damage.  As  such,  this  finding  clarifies  some  of  the  controversy 
associated  with  CCSVI  and  makes  an  important  contribution  to  the  knowledge 
base. Having said this, the results of Beggs et al (Beggs et al., 2013b) suggest that 
intracranial  structural  changes  may  also  be  associated  with  CCSVI.  While  the 
clinical  implications  of  altered  CSF  dynamics  are  unclear,  it  is  noticeable  that 
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Magnano et al’s (Magnano et al., 2012) found increased NPF to be associated with 
increased  T2  lesion  formation  and  NLVV  in  MS  patients.  Consequently,  while 
CCSVI  appears  to  be  primarily  associated  with  biomechanical  phenomena,  the 
possibility  that  it  is  also  associated  with  secondary  pathophysiological  effects 
cannot be excluded.  
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Figure 8. Singular value decomposition (SVD) cluster analysis results (derived 
using the three variables NNF, NPF and NLVV) (p=0.025).
3.6 Hydrodynamic analysis
In 2013 the author published an analytical review paper (Beggs, 2013), in  
which he used hydrodynamic analysis techniques to explain some of the  
findings  described  above.  An  overview  of  this  work  is  presented  in  this  
section, which is supplemented here by additional calculations.  
In 2013 the author published a comprehensive analytical review covering the role of 
venous haemodynamics in MS, leukoaraiosis and NPH (Beggs, 2013). In this paper 
he brought together the knowledge acquired during his various studies and applied 
it  to  three  neurological  conditions,  which  share  some similarities.  In  addition  to 
reporting the findings of relevant published studies, in this paper he also performed 
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independent hydrodynamic analysis of published data to clarify several important 
issues.  For  example,  by  applying  a  mean CSF  absorption  rate  of  0.1031 
mL/min/mmHg (determined experimentally by Cutler et al (Cutler et al., 1968) (see 
Figure 9)) to an average increase of 2.21 mmHg in the SSS pressure (as measured 
in CCSVI positive MS patients by Zamboni et al (Zamboni et al., 2009b)), the author 
was able to show that venous hypertension of this magnitude  would equate to a 
reduction in CSF bulk flow of about 3.26 mm3/beat, which is very close to the mean 
value of 3.4 mm3/beat reported by Magnano  et al (Magnano et al., 2012) for MS 
patients. If this assumption is correct, then this implies that in Magnano et al’s study 
the venous pressure in the SSS was on average 2.31 mmHg higher in the MS 
patients compared with the healthy controls. If the same calculation is performed 
using Gorucu et al’s data (i.e. a mean reduction in CSF bulk flow of 0.12 mL/min in 
the MS patients) (Gorucu et al., 2011), then the predicted venous hypertension is 
1.16  mmHg.  Alternatively,  a  rough  estimate  of  the  likely  venous  hypertension 
associated  with  MS can be calculated using the 63% increase  in  the  hydraulic 
resistance of the extracranial venous pathways found in MS patients compared with 
controls by Beggs et al (Beggs et al., 2012a). Given that the pressure drop through 
the extracranial venous system is normally of the order 3-5 mmHg (Dawson et al., 
2004), then an increase of 63% in the resistance of these vessels would equate to 
a pressure increase in the region 1.89-3.15 mmHg, assuming that the blood flow 
rate remains constant. Collectively, these calculations appear to reveal a consistent 
picture; namely that MS appears to be associated with mild venous hypertension 
(i.e. <5 mmHg) in the dural  sinuses. As such, it suggests that CCSVI is closely 
associated with MS, supporting the findings of Zamboni et al (Zamboni et al., 2012; 
Zamboni et al., 2009c) and many other researchers (Al-Omari and Rousan, 2010; 
Haacke et al., 2012b; Simka et al., 2010; Utriainen et al., 2012; Yamout et al., 2010; 
Zaniewski et al., 2013; Zivadinov et al., 2011a; Zivadinov et al., 2011c). 
When the above calculation is applied to the data collected by Beggs et al (Beggs 
et  al.,  2013b),  the  resultant  mean  venous  hypertension  in  the  CCSVI-positive 
healthy individuals is 1.29 mmHg, which is somewhat less than the 2.21 mmHg 
measured for MS patients by Zamboni et al (Zamboni et al., 2009b). If this is the 
case,  then  it  suggests  that  the  increase  in  the  hydraulic  resistance  of  the 
extracranial veins in CCSVI positive healthy individuals may be less than that in  
CCSVI positive MS patients.
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Figure 9. Relationship between CSF absorption through the arachnoid villi and 
pressure difference between the subarachnoid space and the superior sagittal 
sinus (Cutler et al., 1968).
Numerous  researchers  have  shown  that  MS  is  associated  with  reduced  CBF 
(Adhya et al.,  2006; Ge et al.,  2005; Law et al.,  2004; Varga et al.,  2009).  For 
example, Law et al (Law et al., 2004), observed a mean 53.4% decrease in CBF 
throughout the normally appearing white matter (NAWM) in patients with relapse–
remitting MS compared with controls. Similarly, Ge et al (Ge et al., 2005) observed 
a mean  40.3% decrease in CBF in MS patients, while Varga  et al (Varga et al., 
2009)  recorded  a  decrease  of  15.6%.  Given  that  vascular  perfusion  is  directly 
proportional  to  the  pressure  drop  across  vessels,  it  has  been  postulated  that  
venous  hypertension  in  the  dural  sinuses  might  account  for  the  reduced  CBF 
observed in MS patients (Chung and Hu, 2010). However, when it is considered 
that the cerebral perfusion pressure (CPP) is normally in the region 70 - 90 mmHg, 
it  is  unlikely  that  venous  hypertension  <5  mmHg,  such  as  that  associated  with 
CCSVI,  could  account  for  the  large  reductions  in  CBF reported  in  MS patients 
(Adhya et al., 2006; Ge et al., 2005; Law et al., 2004; Varga et al., 2009). It is much 
more likely therefore, that the reduction in CBF is due to morphological changes in 
the  cerebral  vascular  bed,  rather  than  a  straightforward  reduction  in  perfusion 
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pressure arising from raised pressure in the venous sinuses. In his review paper 
(Beggs,  2013),  the  author  tested  this  hypothesis  by  undertaking  simple 
hydrodynamic analysis of composite data published by  Varga  et al (Varga et al., 
2009). By applying Poiseuille’s Law to Varga et al’s data he was able to show that 
the reduction in cerebral blood volume (CBV) in MS patients observed by Varga et 
al,  was  theoretically  more  than  enough  to  account  for  the  15.6%  reduction  in 
observed  CBF.  While  somewhat  simplistic,  this  analysis  suggests  that  cerebral 
vascular  volumetric  changes  alone,  resulting  in  increased  hydraulic  resistance, 
appear capable of accounting for the reduction in the CBF observed in MS patients. 
Although  the  analysis  of  Varga  et  al’s  data  above  (Beggs,  2013)  assumes  an 
overall reduction in CBV in MS patients, this of course does not necessarily imply 
that  all  the  vessels  in  the  WM  have  uniformly  narrowed.  Putnam  and  Adler’s 
(Putnam and Adler,  1937)  observations  (see  Figure  3)  regarding  periventricular 
lesions  in  individuals  with  MS  would  suggest  otherwise.  However,  in  order  to 
achieve the 8.4% overall reduction in CBV observed by Varga et al (Varga et al., 
2009), systemic changes must be occurring in the WM vascular bed, rather than 
just restrictions appearing at specific focal points. This suggests that morphological 
changes may be occurring in the WM veins of MS patients similar to those found in 
patients with leukoaraiosis (Brown and Thore, 2011; Brown et al., 2009; Moody et 
al., 1995; Moody et al., 1997), where lumenal narrowing of the periventricular veins 
is frequently observed. Alternatively, the reduction in CBV may be due to sections 
of the vasculature disappearing as observed by  Zivadinov  et al (Zivadinov et al., 
2011a), Sinnecker et al (Sinnecker et al., 2013) and Zeng et al (Zeng et al., 2013), 
all  of  whom  found  MS to  be  associated  with  disappearance  of  cerebral  veins; 
something  that  would  tend  to  cause  rerouting  of  the  blood  flows,  ultimately 
increasing the resistance of the cerebral vascular bed. Further evidence supporting 
the opinion that profound changes in the cerebral vasculature occur in patients with 
MS,  comes  from measurements  of  the  mean  transit  time  (MTT)  for  blood  flow 
through the cranium. For example, Law et al (Law et al., 2004), observed a twofold 
increase in vascular MTT,  while Varga et al’s (Varga et al., 2009) and Mancini et al 
(Mancini et al., 2012) recorded increases in MTT of 10% and 8%, respectively, for 
MS patients compared with healthy controls.  
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3.7 Other neurological conditions
This  section  discusses  the  collaboration  between  the  author,  Prof.  
Zivadinov and Dr Chung relating to jugular venous reflux (JVR) in elderly  
patients  with  mild  cognitive  impairment  (MCI)  and  Alzheimer’s  disease  
(AD). The work revealed that JVR, characterized by retrograde venous  
flow, is associated with changes in the intracranial physiology of MCI and  
AD patients, which are difficult to interpret. When viewed in the light of the  
work  relating  to  MS,  the  findings  of  this  work  suggest  that  venous  
anomalies may be associated with generic neuropsychological changes,  
which may influence a variety of neurological conditions.  
In  2013, Dr Chung, Prof.  Zivadinov and the author, along with their  co-authors, 
published two papers relating to jugular venous reflux (JVR) in elderly patients with 
mild cognitive impairment (MCI) and Alzheimer’s disease (AD) (Beggs et al., 2013a; 
Chung et al., 2013). JVR is defined as retrograde flow in the IJVs for >0.5 seconds. 
Although, JVR is not the same phenomenon as CCSVI, it is related to constricted 
cerebral venous outflow and was one of the criteria used by Zamboni et al to define 
CCSVI  (Zamboni  et  al.,  2009c).  These  papers  represent  the  first  studies  to 
specifically investigate the impact of venous anomalies on patients with AD.
The aim of the first study (Chung et al., 2013) was to determine whether of not JVR 
is associated with cerebral  WM changes in individuals with Alzheimer’s disease 
(AD). This study involved 12 AD patients, 24 MCI patients and 17 healthy elderly 
controls, all of whom were closely age-matched. Although the results of the study 
were somewhat inconclusive, they revealed some interesting and novel findings. 
Chief  amongst  these  was finding  that  JVR appears  to  be  associated  with  WM 
changes  in  AD  patients.  In  particular,  there  was  a  significant  decrease  in  the 
periventricular dirty appearing WM (DAWM) volume (p=0.010) in the JVR positive 
AD individuals compared with their JVR-negative counterparts, which was matched 
by a trend for greatly increased periventricular T2 lesion volume in the JVR positive 
individuals (p=0.073). This phenomenon was not observed in either the control or 
MCI groups. Indeed, such was the increase in periventricular T2 lesion volume and 
decrease  in  periventricular  DAWM  volume  that  it  was  possible  using  logistic 
regression analysis to distinguish between JVR-positive and negative AD patients 
with great accuracy (85.7% sensitivity and 80% specificity).   
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In  the  second  study  (Beggs  et  al.,  2013a),  the  author  and  his  co-workers 
investigated whether or not JVR is associated with structural  brain parenchymal 
changes in individuals with MCI and AD. The study which involved 16 AD patients, 
33 MCI patients and 18 healthy elderly  controls, all  of whom were closely age-
matched, revealed JVR to be strongly associated with increased normalized whole 
brain (WB) volume (p=0.014) and normalized GM (p=0.002) volume when all three 
subject groups were aggregated together. However, the impact of JVR was not the 
same in each of the three subject groups. There was a trend towards increased WB 
and GM volumes in the JVR positive subjects in both the MCI and AD groups. 
When the MCI and AD subjects were aggregated together,  significant increases 
were observed in both normalized WB (p=0.009) and GM (p=0.003) volumes for the 
JVR  positive  group.  No  corresponding  increases  were  observed  for  the  JVR 
positive  subjects  in  the  control  group. As  such,  this  suggests  that  JVR is  only 
associated  with  brain  volumetric  changes  in  MCI  and  AD  subjects,  and  not  in 
elderly healthy individuals. 
While  there  is  no  suggestion  from  the  data  collected  that  JVR  is  specifically 
associated with either MCI or AD (the incidence of JVR was similar in the control  
and MCI groups, and actually lower in the AD group), the results of the two studies 
provide strong evidence that JVR is associated with structural changes in the brain 
parenchyma of AD patients. Of particular interest, is the unexpected finding that 
brain ‘atrophy’, normally associated with AD (Forstl et al., 1995; Leung et al., 2013; 
Obara et al., 1994; Shear et al., 1995; Sullivan et al., 1993), appears to be absent  
in JVR positive AD subjects when compared with their JVR negative counterparts. 
Although  the  reasons  for  this  phenomenon  are  unclear,  it  is  unlikely  that  JVR 
prevents atrophy of the brain parenchyma in AD patients; rather it is more likely that  
the  increase  in  parenchymal  volume  is  associated  with  the  retention  of  fluids 
causing the brain to swell. Previous studies involving JVR have provided evidence 
that retrograde-transmitted venous hypertension from JVR can reach  the  cerebral 
venous system (Chung et al.; Wu et al., 2011). It is  therefore  possible that JVR 
retrogradely  transmits  venous  hypertension  into  the  brain,  leading  to  increased 
permeability of the BBB, resulting in vasogenic edema, something that would cause 
the brain tissue to swell. Alternatively, JVR might promote the retention of blood in 
the cerebral veins (Kitano et al., 1964) – something that might increase the volume 
of the brain parenchyma.
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Alzheimer's disease is thought to be caused by an imbalance between amyloid-β 
(Aβ)  production  and  clearance  leading  to  Aβ  accumulation  in  the  CNS,  which 
causes neuronal damage and death, manifesting as progressive clinical dementia 
(Cummings, 2004; Hardy and Selkoe, 2002; Mawuenyega et al., 2010). It has been 
shown that patients with AD have 30% slower clearance of Aβ (Mawuenyega et al., 
2010). One of the possible etiologies of decreased Aβ clearance is impaired CSF 
flow  (Mawuenyega  et  al.,  2010;  Reed-Cossairt  et  al.,  2012).  When  venous 
hypertension occurs in the superior sagittal sinus, CSF absorption is also impaired, 
leading to altered CSF outflow (Cutler et al.,  1968; Schaller, 2004; Schaller and 
Graf,  2004).  It  is  known that JVR can induce hypertension in the dural  sinuses 
(Chung et al.; Wu et al., 2011) and that this can alter intracranial CSF dynamics 
(Beggs, 2013). Therefore, it may be that retrograde-transmitted venous pressure 
associated  with  JVR,  inhibits  CSF  absorption  into  the  SSS  (Ekstedt,  1978).  
Absorption of CSF into the dural venous sinuses requires a pressure gradient of 
about  5–7  mmHg (McCormick  et  al.,  1992;  Olivero  et  al.,  1988). Therefore,  an 
increase in venous pressure of few mmHg due to occlusion of the venous drainage 
pathways (Zamboni et al., 2009b), or reflux, will tend to inhibit the bulk flow of CSF, 
as observed by Zamboni et al (Zamboni et al., 2009d). If CSF flow is inhibited, then 
this  might result in increased biochemical concentrations in the CSF.  Given that 
overproduction  of  Aβ is  thought  to  damage WM in  AD patients  (Querfurth  and 
LaFerla,  2010),  it  has  been  postulated  (Reed-Cossairt  et  al.,  2012)  that 
accumulation of Aβ  in the CSF, arising from venous hypertension, may precipitate 
the onset of AD. While the data collected by the author and his co-workers does not  
support the hypothesis that JVR causes AD, the possibility that the accumulation of 
Aβ in the CSF is affecting periventricular T2 lesion formation in patients with AD 
cannot be excluded. Indeed, the accumulation of metabolites in ventricular CSF, 
due to venous hypertension, may be involved in other neurological pathologies.
Although JVR is related to CCSVI, it is important to note that the AD studies above 
investigated the impact of retrograde venous reflux on the brain parenchyma and 
not constricted venous outflow. Therefore the findings of these studies should be 
treated  with  caution,  when  drawing  any  inference  with  respect  to  MS. 
Notwithstanding this, the findings of these studies add weight to the opinion that 
venous  outflow  anomalies  are,  under  certain  circumstances,  associated  with 
changes in the intracranial  physiology. Having said this, it  is noticeable that the 
33
structural changes associated with JVR in the MCI and AD subjects, were absent in 
the  control  group,  suggesting  that  structural  changes  in  the  brain  parenchyma 
associated with JVR are due to a combination of factors and not just retrograde 
venous  reflux.  Because  CSF  data  was  not  collected  in  the  AD  studies,  the 
possibility that JVR is associated with altered CSF dynamics cannot be ruled out.
3.8 Discussion
In this section the work of the author is discussed and evaluated in the light  
of the findings of other researchers. 
Throughout  his  studies,  the  author  has  sought  to  translate  and  synthesize  his 
findings (and those of his co-workers) to explain any observed physiological (and 
pathophysiological) changes. This has resulted in two review papers (Beggs, 2013; 
Haacke et al., 2012a). Preliminary work relating to the role of the venous system in 
MS was published in an early review paper (Haacke et al., 2012a), which the author 
wrote in collaboration with Prof. Haacke (Department of Radiology, Wayne State 
University, Detroit, USA). While this paper presented some useful insights into the 
possible role of venous anomalies in the pathophysiology of MS, it did not include 
much of the work subsequently undertaken by the author and his collaborators. In  
2013 the author published a comprehensive analytical review, which built on his 
initial work and covered the role of venous haemodynamics in MS,  leukoaraiosis 
and  NPH  (Beggs,  2013).  In  this  paper  he  drew  together  the  venous  and  CSF 
strands of his work, to show that these apparently disparate neurological conditions 
exhibited similarities, which may relate to alterations in the intracranial fluid system. 
He was also able to show that the reduced CSF bulk flow observed in MS patients 
was  consistent  with  venous  hypertension  in  the  dural  sinuses  arising  from 
constriction of the cerebral venous drainage pathways (see discussion in section 
3.6 above). As such, this paper forms the basis of much of the discussion section 
presented here.
3.8.1 CCSVI controversy
While the work of the author and his co-workers suggests that MS is associated 
with a variety of venous and CSF anomalies, including constricted cerebral venous 
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outflow,  the  author  recognizes  that  many  researchers  hold  a  contrary  position. 
CCSVI  has  proved  to  be  a  highly  contentious  issue  amongst  the  MS research 
community,  with  many  researchers  doubting  its  validity  as  a  physiological 
phenomenon (Baracchini et al., 2012; Doepp et al., 2010; Doepp et al., 2011; Khan 
et al., 2010; Mayer et al., 2011; Wattjes et al., 2011a). Proponents for and against 
CCSVI have published contradictory studies defending their respective positions, 
with the result that this has lead to much confusion. For example, Zamboni et al 
(Zamboni  et  al.,  2009c),  Zivadinov et al  (Zivadinov et  al.,  2011c),  Al-Omari  and 
Rousan  (Al-Omari  and  Rousan,  2010),  Simka  et  al  (Simka  et  al.,  2010)  and 
Zaniewski et al (Zaniewski et al., 2013) all found statistically significant differences 
between the venous outflow characteristics in MS patients and healthy controls, 
suggesting the presence of CCSVI. By contrast Doepp et al (Doepp et al., 2010), 
Krogias et al (Krogias et al., 2010), Baracchini et al (Baracchini et al., 2011), Mayer 
et al (Mayer et al., 2011) and Traboulsee et al (Traboulsee et al., 2013) all found no 
difference in the venous blood flow between healthy controls and MS patients. One 
possible  explanation,  for  the  large  discrepancies  found  between  these  various 
studies might be the use of  ECDS to examine the venous blood flow in patients. 
While ECDS is generally used to diagnose CCSVI in patients, due to the floppiness 
of the vessels involved and the variability of the venous vasculature, the technique 
needs to be handled with great care and is open to misinterpretation (Menegatti et 
al., 2010). As others (Parvey et al., 1989) have pointed out, if venous sonography is  
not undertaken in the correct manner, erroneous results can frequently occur. 
Aware of difficulties associated with venous ECDS, a number of researchers have 
turned to  MRI and MRV. However,  as with  the studies that  relied  on ECDS to 
identify venous abnormalities, the results have been mixed. Wattjes et al (Wattjes 
et al., 2011b), who used MRV in a study involving 20 MS patients and 20 healthy 
controls, found venous abnormalities in only 10 MS patients and in 8 controls. They 
concluded  that  venous  abnormalities  are  an  anatomical  variant,  without  any 
correlation with MS. Similar results were obtained by Sundstrom et al (Sundstrom 
et  al.,  2010)  who  used  phase-contrast  MRI  and  contrast-enhanced  MR 
angiography, to identify venous abnormalities and changes in cerebrospinal fluid 
(CSF) flow in a study involving 21 RR MS patients and 20 healthy controls. They 
found no  differences between the  two groups regarding  internal  jugular  venous 
outflow, aqueductal  cerebrospinal  fluid flow, or the presence of IJV blood reflux. 
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Venous stenosis of the IJVs was only identified in 3 of 21 MS cases. In contrast to 
these findings, Haacke et al (Haacke et al., 2012b), in a study involving 200 MS 
patients  in  which contrast-enhanced time-resolved MR angiography and time-of-
flight  MRV  was  used,  found  that  68%  of  patients  showed  IJV  structural 
abnormalities. They also found that total IJV blood flow was significantly lower in 
those patients who exhibited stenosis, compared with the non-stenotic group. In a 
separate  study  (Utriainen  et  al.,  2012),  involving  111  MS patients  and  using  a 
similar  methodology,  the  same  team,  found  that  55%  of  the  MS  patients  had 
stenotic  IJVs.  Yamout  et  al  (Yamout  et  al.,  2010)   performed  venous  MR 
angiography  in  42  MS  patients  in  various  phases  of  the  disease:  at  onset;  in 
subjects with a disease duration <5 years; and in those whose disease duration 
was  >10  years.  They  found that  extracranial  venous  stenosis,  although rare  at 
onset (7/29), became much more frequent in subjects who have had MS >10 years 
(12/13). From this they concluded that although related to MS, CCSVI was unlikely 
to cause the disease as was more likely to be a late onset secondary phenomenon.
Despite  conflicting  studies  regarding  CCSVI,  there  appears  to  be  a  body  of 
evidence linking the condition with MS. Recent meta-analysis of published evidence 
by  Zwischenberger  et  al  (Zwischenberger  et  al.,  2013)  demonstrated  a  strong 
correlation between CCSVI and MS (odds ratio 1.885,  p<0.0001), although there 
was no evidence that CCSVI played a causative role in MS. This opinion is shared 
by  the  Canadian  Institute  of  Health  Research expert  panel,  which  after  meta-
analysis of the evidence concluded: “Our findings showed a positive association  
between CCSVI and MS. However, poor reporting of the success of blinding and  
marked  heterogeneity  among  the  studies  included  in  our  review  precluded  
definitive  conclusions” (Laupacis  et  al.,  2011).  One  of  the  reasons  for  this 
heterogeneity has been the wide variety of methodologies used. Indeed, Ghezzi et 
(Ghezzi et al., 2011) in their review of CCSVI and MS, attributed the large variability  
in the reported results to differences in the methodologies used to diagnose venous 
abnormalities, stating: “It is not clear which is the gold standard to assess CCSVI:  
Doppler sonography, venous MRI, or venous angiography.” This point is highlighted 
in  a  study  by  Zivadinov  et  al  (Zivadinov  et  al.,  2011b),  which  specifically 
investigated this issue. This study involving 10 patients with MS who underwent an 
MRV examination, in addition to  ECDS and catheter venography (considered the 
‘gold standard’).  The results revealed that the sensitivity and specificity of ECDS, 
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for detecting IJV abnormalities relative to catheter venography in patients with MS, 
was 82% and 100%, respectively. By comparison, the figures were 99% and 33% 
for 2D time-of-flight MR venography (TOF), and 99% and 39% for 3D time-resolved 
imaging of contrast kinetics (TRICKS). No agreement was found between TOF and 
catheter venography in 70% of patients with MS and between TRICKS and catheter 
venography in 60% of patients with MS. From this  Zivadinov et al concluded that 
conventional  MRV  is  of  limited  value  for  assessing  IJV  anomalies  for  both 
diagnostic and post-treatment purposes.
Well  aware  of  the  controversy  surrounding  CCSVI,  the  author  has  consistently 
sought to distance himself from the CCSVI debate by focusing instead on objective 
study  of  venous  and  CSF  anomalies  associated  with  MS  using  a  systems 
engineering approach. In doing so, his aim has been simply to characterise the 
venous and CSF anomalies associated with the MS, and to use the data acquired 
to gain deeper insights  as to whether or not these anomalies play any role in the 
pathophysiology of MS. 
 
3.8.2 Cerebrospinal fluid pulsatility
Although  a  controversial  finding,  which  is  disputed  by  some  researchers,  the 
hydrodynamic analysis presented in (Beggs, 2013) and expanded  in section 3.6 
above, suggests that mild venous hypertension may be a feature of MS. As such, 
this analysis draws together the findings of Zamboni et al (Zamboni et al., 2009d), 
Magnano  et  al (Magnano et  al.,  2012),  Beggs  et  al (Beggs  et  al.,  2013b) and 
Gorucu et al (Gorucu et al., 2011) into a single model linking constricted cerebral 
venous outflow with reduced CSF bulk flow in the AoS. With respect to this, there 
appears to  be parallels  between MS and  NPH; NPH is  thought by some to  be 
associated  with  venous  hypertension  in  the  SSS  (Nakahara  et  al.,  2011)  and 
appears to be associated with significantly reduced CSF resorption into the SSS 
through the AV (Bradley, 2000; Tullberg et al., 2000), something that is consistent 
with venous hypertension in the dural sinuses. Furthermore, mirroring the findings 
of  Zamboni  et  al  (Zamboni  et  al.,  2009d),  Gorucu  et  al  (Gorucu  et  al.,  2011), 
Magnano et al (Magnano et al., 2012) relating to MS, Luetmer et al (Luetmer et al., 
2002), Schroth & Klose (Schroth and Klose, 1992), Gideon et al (Gideon et al.,  
1994),   Kim et al (Kim et al., 1999), El Sankari et al (El Sankari et al., 2011) and 
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Bradley (Bradley et al., 1996) all found CSF pulsatility in the AoS to be markedly 
greater in NPH patients compared with controls.  This suggests that MS and NPH 
might share some physiological mechanism that not only inhibits CSF resorption 
into the SSS, but also promotes increased pulsatility in the AoS. 
There is evidence that reduced intracranial compliance (Bateman, 2000; Bateman, 
2008b; Mase et al., 2008; Miyati et al., 2007) is a feature of NPH (Bateman, 2000; 
Bateman, 2008b; Williams, 2008a; Williams, 2008b),  and it  may be that venous 
hypertension  reduces  the  compliance  of  the  cortical  bridging  veins  and  AV  in 
individuals with NPH. If this is the case, then there is good reason to believe that  
mild venous hypertension might influence the dynamics of the CSF pulse. When 
CSF flows back into the cranium from the spine during diastole, the returning CSF 
has to be accommodated somewhere within the cranium, before it eventually forces 
its way up the AoS, dilating the lateral ventricles. In healthy individuals the incoming 
CSF fills  the SAS,  compressing compliant  elements  such as the  cerebral  veins 
(Williams, 2008a; Williams, 2008b). Approximately 70% of intracranial blood volume 
is  located  within  the  venous  compartment,  much  of  it  in  thin-walled  veins  that 
readily collapse under small changes in transmural pressure. Given that the cortical 
veins that bridge the SAS are much more compliant than the arterial vessels, it is  
likely that these vessels compress to accommodate some of the incoming CSF. 
Other compliant elements include the AV, which deform to accommodate changes 
in the intracranial CSF volume. So when the cervical CSF flow reverses direction, 
once  again  flowing  into  the  cranium,  these  compliant  elements  dampen  the 
pressure wave and assist in accommodating the additional fluid. It can therefore be 
postulated that only when the compliance in the SAS has largely been taken up, will 
the  CSF  start  to  flow  positively  up  the  AoS.  If  this  is  the  case,  then  venous 
hypertension in the dural sinuses is likely to substantially reduce the compliance of 
the SAS; something that is theoretically likely to result in increased CSF NPF in the 
AoS towards the lateral ventricles.
While the increase in aqueductal pulsatility observed in MS and NPH patients may 
appear  consistent  with  the  venous  hypertension  model  (and  by  inference 
constricted venous outflow), it  is  important to remember that other physiological  
mechanisms may be at work. For example, the increase in CSF pulsatility may be 
due to enlarged lateral ventricles, which are a common feature of both neurological 
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conditions. In MS, dilated ventricles are thought to be primarily due to brain atrophy 
(Dalton et al., 2006; Dalton et al., 2002), whereas in NPH, the accumulation of CSF 
is thought to contribute to enlarged ventricles (Bradley, 2000). Notwithstanding this, 
the presence of enlarged lateral ventricles might account for increased CSF flow in  
the AoS. Having said this, this cannot explain why Beggs et al (Beggs et al., 2013b) 
found CCSVI to be associated with increased CSF pulsatility in the AoS of healthy 
individuals without any apparent brain atrophy.
3.8.3 Cerebral vascular changes
Collectively the work of the author and professors Zivadinov and Zamboni provides 
evidence for a  link  between MS and:  (i)  constricted venous  outflow;  (ii)  altered 
intracranial CSF dynamics; and (iii)  changes in the cerebral venous vasculature. 
However,  the  evidence  linking the cerebral  vascular  changes  in  MS with  either 
CCSVI or  altered CSF dynamics is  much weaker.  The fact  that  Zivadinov et  al 
(Zivadinov et al., 2011a) found a strong statistical correlation (p<0.0001) between 
severity  of CCSVI and decreased venous volume in MS patients,  suggests that 
cerebral  vascular  changes  in  MS  may  be  associated  with  constricted  venous 
outflow. However,  at  this  point  in  time the nature of  this  link,  if  it  exists,  is  not  
known. Notwithstanding this, from the body of work undertaken so far it is possible 
to postulate theories as to what might be happening.
It is thought that the infiltration of leukocytes across the BBB into the CNS is an 
essential step in the pathophysiology of MS. Chemokines on the endothelial lumen 
bind to receptors on the leukocytes and initiate a cascade of events that culminates 
in breaching of the BBB (Holman et al., 2011). The ease with which the leukocytes 
are able to enter the brain parenchyma depends on the chemokines present and 
the  characteristics  of  the  endothelia.  While  the  BBB  has  traditionally  been 
considered a uniform element, there is evidence of heterogeneity within the BBB 
(Holman et al.,  2011),  which varies depending on it  location within the cerebral  
vascular bed. In particular, there is considerable heterogeneity in the tight junctions 
between the endothelial cells (Simionescu et al., 1975; Simionescu et al., 1976), 
which appear weaker and more leaky in the cerebral collecting veins (Nagy et al., 
1984).  Furthermore,  the expression of  the chemokine CXCL12 (which regulates 
leukocyte access to the CNS parenchyma) at the abluminal endothelial membrane 
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appears  altered  in  the  post-capillary  venules  in  MS  (Holman  et  al.,  2011); 
something  that  correlates  strongly  with  the  perivascular  infiltration  of  T-cells 
(McCandless et al., 2006; McCandless et al., 2008). It has also been shown that 
the  blood  flow  characteristics  of  the  venules  tend  to  promote  margination 
(Goldsmith  and  Spain,  1984;  Holman  et  al.,  2011),  with  the  result  that  the 
leukocytes are  displaced to the periphery of  the vessels (Goldsmith  and Spain, 
1984), where they come into contract with the endothelial cells (Ley, 1996). This 
may  facilitate  enhanced  intercellular  interactions,  leading  to  activation  of  the 
integrins  on  the  leukocytes  resulting  in  firm  attachment  to  the  endothelial  wall. 
Collectively, this suggests that the cerebral venules and veins in MS patients may 
be more susceptible to inflammatory damage, than the arterioles and capillaries. It  
is therefore possible that focal inflammatory events might result in occlusion of the 
venules and smaller veins, leading to rerouting of the blood flows. Strong evidence 
in support of this hypothesis comes from Gaitan et al (Gaitan et al.,  2013), who 
found that in MS patients the mean diameter of the intralesional veins was >30% 
smaller than that of the perilesional (p<0.001) and extralesional (p<0.001) veins. By 
comparison,  the  perilesional  and  extralesional  MS veins  had  a  diameter  >20% 
larger than equivalent non-MS veins (p<0.001),  while the intralesional  MS veins 
were  smaller  their  counterparts  in  healthy  controls  (p<0.001).  Gaitan  et  al  
interpreted this as evidence that in the intralesional veins were being compressed 
by perivascular inflammatory cuffs. If this process is occurring in the brains of MS 
patients, then it might lead to complete occlusion of some veins and rerouting of the 
blood through other vessels; something that might result in reduced venous density 
in the brain parenchyma, just as Zivadinov et al (Zivadinov et al., 2011a), Sinnecker 
et al (Sinnecker et al., 2013) and Zeng et al (Zeng et al., 2013) found.
Because  inflammatory  compression  of  the  veins  would  tend  to  increase  the 
hydraulic resistance of the whole vascular bed and thus reduce CBF, it is likely to 
be accompanied by increased hypoxic stress and ischaemia.  Several researchers 
have found similarities between leukoaraiosis and MS (D'Haeseleer et al., 2011; De 
Keyser  et  al.,  2008).  Leukoaraiosis  is  characterized  by  periventricular 
hyperintensities (Helenius et al., 2002) and reduced CBF in the WM (Kobari et al., 
1990),  and it is thought that ischaemia, resulting from poor perfusion, is a major  
contributing factor (Brown et al.,  2007; Moody et al.,  1995; Moody et al.,  1997).  
Graumann  et  al  (Graumann  et  al.,  2003),  investigating  gene expression  in  the 
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NAWM of patients with secondary progressive MS and healthy controls, showed 
that the MS patients exhibited consistent differences in the expression of hypoxia-
inducible factor (HIF)-1a compared with controls. Similar up-regulation of HIF-1a in 
cerebral WM was found by Fernando et al (Fernando et al., 2006) to be associated 
with leukoaraiosis, which they attributed to WM hypoperfusion.    
While  the  inflammatory  compression  hypothesis  above  has  merit,  it  does  not 
explain why Zivadinov et al (Zivadinov et al., 2011a) found the loss of the cerebral 
veins in MS patients to be so strongly correlated with severity of CCSVI. Similarly, it  
does not explain why MS appears to be associated with CCSVI. It  may be that 
other  alternative  mechanisms are  at  work in  MS. One possibility  is  that  CCSVI 
causes  venous  hypertension  in  the  dural  sinuses,  and  that  this  reduces  the 
compliance in the SAS, which alters the  behaviour of the Starling resistor  (Holt, 
1941; Katz et al., 1969; Lyon et al., 1980; Lyon et al., 1981) regulating blood flow in 
the cortical  veins.  Blood flow through the cortical  bridging veins is controlled by 
sphincters, which regulate discharge into the SSS (Luce et al., 1982; Vignes et al., 
2007).  These vessels collapse, when the transmural pressure reaches a certain 
threshold,  occluding blood flow (Schaller,  2004),  and  are  thus  very  sensitive  to 
small  changes in transmural  pressure. Because they are required to ‘open’  and 
‘close’ to regulate blood flow from the cortex, the cortical venous pressure is only 
about 2-5 mmHg higher than the intracranial pressure (ICP) (Schaller, 2004), which 
means that small changes in ICP or venous pressure can have a substantial effect 
on the behaviour of blood flow from the cortex. Indeed, it has been estimated that a 
change of as little as 1.5 mmHg in the difference between ICP and the pressure in 
the  bridging  veins  could  be  responsible  for  the  difference  between  severe 
hyperemia and ischaemia (Schaller, 2004). Given that MS may be associated with 
venous hypertension in the dural sinuses >2 mmHg (Zamboni et al., 2009b), it can 
be hypothesized that this could have a profound effect on blood flow in the cortex. 
While it is difficult to say how this might influence haemodynamic behavior in the 
cortex, it is noticeable that Kidd et al  (Kidd et al., 1999) found GM lesions in MS 
patients to be exclusively located adjacent to cortical veins. 
It may also be that venous hypertension in the dural sinuses reduces compliance in  
the SAS, altering the  behaviour of the cerebral windkessel mechanism.  While the 
precise  behaviour  of  the  intracranial  fluid  system  under  conditions  of  venous 
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hypertension is not fully understood, there is evidence that occlusion of the venous 
drainage  pathways,  causes  blood  to  accumulate  within  the  cranium.  In  an 
experiment involving healthy subjects, Kitano et al (Kitano et al., 1964) showed that 
compression of the IJVs could result in a 5-20% increase intracranial blood volume. 
Frydrychowski  et  al  (Frydrychowski  et  al.,  2012)  also  performed  bi-lateral 
compression of the IJVs on healthy individuals and found that it caused a reduction 
in the width of the SAS – a finding consistent with increased CBV. Furthermore,  
they observed that during compression of the IJVs, the pulsatility of the pial arteries 
traversing the SAS increased by 107%. This suggests that occlusion of the venous 
drainage pathways,  reduces  compliance  of  the intracranial  space,  impairing the 
windkessel  mechanism,  with  the  result  that  the  blood  entering  the  cerebral 
microvasculature becomes more pulsatile.  Frydrychowski et al  (Frydrychowski et 
al.,  2012)  concluded  that  this  mechanism  potentially  linked  jugular  outflow 
insufficiency  with  arterial  small  vessel  cerebral  disease.  As  such,  their  work 
appears to corroborate that of Bateman (Bateman et al., 2008), who found vascular 
dementia to be associated with greatly increased pulsatility in both the basil venous 
and straight sinus flows. However,  they applicability  of  this finding to MS is not 
known.
3.8.4 Lesion formation
While the author’s work primarily focused on venous and CSF dynamics associated 
with MS, some evidence was accumulated linking altered venous/CSF dynamics 
with pathological  changes.  For example,  Magnano et al  (Magnano et al.,  2012) 
found T1- and T2 lesion volumes to be positively correlated (p=0.001 and p=0.01,  
respectively)  with  aqueductal  NPF in  MS patients,  suggesting  that  altered  CSF 
dynamics might contribute in some way to lesion formation. While the reasons for 
this are unclear, it can be postulated that increased NPF might be associated with 
ventricular  reflux  of  CSF  into  the  brain  parenchyma.  NPH  is  associated  with 
significantly reduced CSF absorption into the SSS (Bradley, 2000; Tullberg et al.,  
2000).  Commenting  on  this,  Bateman  (Bateman,  2000)  suggested  that  CSF 
resorption might be occurring in the subependymal brain parenchyma. Ventricular 
reflux  of  fluid  has  been  shown  to  be  a  characteristic  of  communicating 
hydrocephalus (Algin et al., 2011; Tator et al., 1968), with the periventricular tissue 
characterized by disruption of the ependyma, oedema, neuronal degeneration, and 
ischaemia  (Tullberg  et  al.,  2001).  If  ventricular  reflux  of  CSF  is  breaching  the 
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ependymal wall  in NPH, then this might result  in oedemas in the periventricular 
parenchyma;  something  which  could  inhibit  CBF in  this  region  (Momjian  et  al., 
2004).  CBF has been found to be generally lower in NPH patients than in normal 
controls (Graff-Radford et  al.,  1987; Larsson et  al.,  1994; Momjian et  al.,  2004;  
Owler et al., 2004), mirroring a similar phenomenon in MS patients (Ge et al., 2005; 
Law et al., 2004; Varga et al., 2009). Given that many researchers (Bradley et al., 
1996; El Sankari et al., 2011; Gideon et al., 1994; Kim et al., 1999; Luetmer et al.,  
2002; Schroth and Klose, 1992) have reported altered CSF dynamics in NPH that 
are similar to those observed in MS  (Gorucu et al., 2011; Magnano et al., 2012; 
Zamboni et al., 2009d) (i.e. increased  CSF pulsatility in the AoS), it may be that 
CSF reflux through the ependymal wall is a feature of MS. If this were the case,  
then CSF reflux might contribute to periventricular lesion formation in MS patients, 
as has been proposed by Thompson and Zeman (Thompson and Zeman, 1992). 
Adams et al (Adams et al., 1987) and  Damadian and Chu  (Damadian and Chu, 
2011)  also  implicated  CSF  leakage  into  the  brain  parenchyma  with  MS  lesion 
formation in the periventricular region. While Magnano et al (Magnano et al., 2012) 
did not specifically investigate ventricular reflux of CSF, they found both the lateral 
ventricle and lesion volumes to be positively correlated with the aqueductal NPF in 
MS patients. Given that an increase in CSF pulsatility might promote ventricular 
reflux, this raises intriguing questions as to whether or not ventricular reflux might 
also be a feature of MS.
Further evidence linking venous anomalies with pathological changes, comes from 
the author’s work  with Dr Chung and Prof. Zivadinov (Chung et al., 2013), which 
revealed  that  in  subjects with  AD,  JVR  was  associated  with  WM  changes.  In 
particular,  they  found  JVR  to  be  associated  with  a  decrease  in  periventricular 
DAWM volume and an increase in periventricular T2 lesion volume in AD patients. 
The measurement of DAWM is relatively unexplored territory in neurodegenerative 
disorders and aging. Most of the work on DAWM has been performed in patients 
with MS [20, 23-27], and although the concept of DAWM remains largely under 
investigation, it appears to have potential as a diagnostic metric. Image-pathology 
correlation studies reveal DAWM, compared with T2 WM lesions, to be associated 
with  mild  BBB  breakdown  and  myelin  loss  [20,  23-27].  Therefore,  it  can  be 
suggested that DAWM may represent an earlier stage of WM pathology in elderly 
[25, 26], which is followed at a later stage, by T2 WM lesion formation [35-38].
43
Chapter 4: Conclusions and future work
4.0 Conclusions
From  the  body  of  work  presented  above  it  is  possible  to  draw  the  following 
conclusions:
1. It is possible to characterize the dynamics of the cerebral venous drainage 
system using cervical plethysmography. 
2. Although not exclusive to MS, constricted cerebral venous outflow appears 
to be a phenomenon associated with MS.
3. Constricted  cerebral  venous  outflow  in  MS  patients  is  associated  with  a 
substantial  increase in the hydraulic resistance in the extracranial  venous 
drainage pathways from the brain to the heart.
4. MS appears to be associated with reduced CSF bulk flow which is indicative 
of mild hypertension in the dural sinuses (i.e. <5 mmHg); something that is  
also consistent with constricted cerebral venous outflow.
5. MS  is  associated  with  increased  CSF  pulsatility  in  the  AoS.  While  the 
reasons for this are unclear, this phenomenon appears to be associated with 
constricted cerebral venous outflow, suggesting that venous hypertension in 
the  dural  sinuses  might  be  reducing  intracranial  compliance,  leading  to 
altered CSF dynamics.
6. T2 lesion volume in MS patients is positively correlated with the NPF of CSF 
in the AoS. This suggests that altered CSF dynamics may be implicated in 
the  formation  of  lesions  in  MS  patients,  although  the  pathophysiological 
mechanisms involved are not known.
7. Constricted  cerebral  venous  outflow  appears  to  be  associated  with 
intracranial  physiological  changes  in  healthy  individuals.  These  changes 
appear to be primarily associated with altered CSF dynamics, which appear 
to mirror those found in MS patients. 
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8. MS is associated with profound changes in the cerebral venous vasculature, 
which result in reduced venous density in the brain parenchyma and reduced 
CBF. While the reasons for this are unclear, there is evidence that several 
different pathophysiological mechanism may be involve.
9. Jugular venous reflux is associated with intracranial structural changes in AD 
patients,  which  result  in  more  severe  WM  changes  and  increased  brain 
parenchymal volume, compared with JVR negative AD patients. However, 
the reasons for these phenomena are unclear.
4.1 Future work
While  the  work  presented  here  clarifies  some  issues  relating  to  the  nature  of 
venous and CSF anomalies in MS, it raises many other research questions that  
need to be answered. Chief amongst these is the connection (if any) between the 
biomechanical  changes associated with constricted cerebral  venous outflow and 
pathology in the brain parenchyma. In particular, the possible role of ventricular 
reflux  of  CSF in  MS needs  to  be  investigated.  Although there  is  circumstantial 
evidence  suggesting  that  ventricular  reflux  in  MS  might  be  involved  in  lesion 
formation and changes in the venous vasculature in the periventricular region, this 
is far from proven. Consequently, more work is required to explore this issue. More 
work is also required to establish whether or not the loss of the venous vasculature 
in the brain parenchyma of MS patients is connected in anyway with constricted 
cerebral venous outflow or alterations in the intracranial CSF dynamics.  
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